March 25, 2022 (continued)

PLEASE NOTE: The schedule is preliminary, tentative, and subject to change. We will live ‎stream and record keynote presentations and select breakout sessions for virtual ONLY ‎attendee participation. Pre-conference Workshops will be held onsite, for “in-person” only ‎participation.  Virtual Registration for the conference will be offered separately in early 2022 ‎for those who cannot or prefer not to travel. Thank you for your patience as navigate and ‎accommodate.‎

 

REGISTER NOW

 

‎‎2:45pm – 4:15pm ‎        90-MINUTE BREAKOUT SESSIONS - SYMPOSIA


BOS09: Autism: New Directions in QEEG Subtypes and Neurofeedback for Autistic Spectrum Disorder

Presented By: ‎

  • Michael Linden, Psychologist
  • Estate (Tato) Sokhadze, Ph.D.‎
  • David Cantor, PhD, Psychology

SESSION SYNOPSIS: The prevalence of Autism has increased dramatically to epidemic proportions, ‎however there is no brain functioning test regularly utilized in diagnosis.  Aspergers remains highly ‎undiagnosed in both children and adults; many people with Aspergers are misdiagnosed (ADHD, ‎Anxiety, Oppositional Defiant Disorder, Bipolar) and prescribed medications which make their ‎symptoms worse.  This talk will present QEEG diagnosis and new directions in Neurofeedback ‎treatment of ASD (Autism, Aspergers).    The presenters (David Cantor, Ph.D., Michael Linden, Ph.D., ‎Sato Sokhadze, Ph.D.) have published numerous research articles since 2004 (Biofeedback & Self-‎Regulation; Journal of Neurotherapy; Autism Science Digest; Images of Autism; etc.) and presented at ‎Autism One, TACA, ISNR, ECNS, National Autism Association, and other national and international ‎conferences about QEEG brainmap subtypes of ASD.  The use of QEEG brain mapping to discover ‎which subtype of Autism and Aspergers be explained.      Biofeedback & Neurofeedback have been ‎used successfully to improve anxiety, communication, social skills and attention in ASD since 1994 ‎‎(Biofeedback and Self-Regulation, 2010). Over our many years of experience, there have been ‎numerous types of biofeedback and neurofeedback utilized. Standard (QEEG Guided Neurofeedback, ‎biofeedback) and new types of Neurofeedback home training for younger children (Mente auditory ‎stimulation) & social-emotional regulation (Socialize ACE) will be presented. Research studies with ASD ‎and Neurofeedback, including results of QEEG, fMRI and DTI will be reviewed.‎

  • Hot Topics
  • Intermediate
  • ‎40% Clinical/60% Research‎

LEARNING OBJECTIVES: ‎
Understand QEEG subtypes pattens in individuals with Autistic Spectrum Disorder.‎
Learn about new types of Neurofeedback home training options for ASD.‎
Learn about new developments in Auditory Stimulation Neurfeedback for Young Children with ASD.‎

TARGET AUDIENCE: psychologists/therapists, physicians/neurologists, neurofeedback therapists, ‎educators

DIVERSITY CONSIDERATIONS: QEEG and Neurofeedback do not have cultural issues and apply to all ‎cultures.‎


BOS10: Integrating Bio- and Neurofeedback in Psychedelic Assisted Therapies

Presented By:

  • Jeff Tarrant, PhD, BCN

SESSION SYNOPSIS: Interest in psychedelic-assisted therapies (PAT) has increased dramatically based ‎on clinical research showing that Psilocybin (magic mushrooms), MDMA, and Ketamine can be ‎effective for treatment-resistant depression, PTSD, addictions, end-of-life anxiety, and obsessive-‎compulsive disorder. However, it is important to recognize that these benefits are attained within ‎contexts that provide specialized preparation for the psychedelic experience, active support during, ‎and structured integration sessions for follow-up.    Although it is tempting to view psychedelics as a ‎‎“magic bullet” that can permanently solve personal problems and mental health conditions, it is ‎probably more accurate to think of them as medicines that induce a state of increased brain plasticity, ‎also known as a "pivitol mental state". This neuroplasticity facilitates new ways of thinking, feeling, ‎and behaving for those who use it medicinally (Carhart-Harris & Friston, 2019). With this ‎understanding, it becomes increasingly important to 1) prepare the brain/nervous system for the shift ‎experienced during a psychedelic session, and 2) to take advantage of the increased flexibility created ‎by the experience in the days following a psychedelic session. In addition to incorporating targeted ‎psychotherapy, it can also be helpful to include mental state training in the form of neurofeedback ‎and neurofeedback-guided meditation (neuromeditation) into PAT’s.    This workshop will present the ‎neuroscience, research findings, and practice of psychedelic assisted therapies. We will explore this ‎data in the context of the entropic model of consciousness, and conditions related to therapeutic ‎outcomes. We will discuss how neurofeedback therapies are poised to offer a method to support the ‎various states of awareness that underlie positive outcomes as well as practices that help sustain the ‎‎“afterglow” after a psychedelic session. A model for neurofeedback supported PAT’s will be presented ‎along with case study data.‎

  • Basic Science
  • Intermediate
  • ‎75% Clinical/25% Research‎

LEARNING OBJECTIVES: ‎

  • Describe the science behind psychedelic assisted therapies (PAT's)‎
  • Discuss the entropic model of consciousness and its connection to mental health
  • Apply bio and neurofeedback approaches to the preparation and integration phases of PAT's
  • Explain a model of neurofeedback supported PAT

TARGET AUDIENCE: Clinicians interested in learning more about bio- and neurofeedback approaches ‎to complement and advance psychedelic assisted therapies.‎


DIVERSITY CONSIDERATIONS: We strongly emphasize the importance of recognizing and honoring ‎diversity-in all its forms. The approaches taught in this workshop are discussed in the context of ‎individual differences based on a person's culture, background, and neurological state.‎

 

BOS30: Bridging Physiology, Science and Daily Life when Providing Stress Management Services

Presented By: ‎

  • Harry van der Lei, PhD
  • Wesley Sime, PhD, MPH

SESSION SYNOPSIS: Stress is a normal aspect of life, but stress is also often misunderstood and ‎mismanaged. Poorly managed stress can ‎vastly affect our performance and health. Motivation, ‎education, assessment, and training are important components ‎when delivering stress management ‎services. In addition, an evidence-based framework and objective measures can ‎be very helpful when ‎providing clients tools how to change and enhance their stress management in life. The speakers ‎will ‎deliver a complementary presentation of a comprehensive stress management education, ‎assessment, and ‎training program. This program is based on the presenters’ practical experience and ‎includes an applied-research ‎based stress model and a recent developed stress management ‎consulting service. ‎

  • Clinical Interventions and Optimal Performance
  • Intermediate
  • ‎50% Clinical/50% Research‎

LEARNING OBJECTIVES: ‎

  • The learner will be explained how stress can be described from a clinical and a performance ‎perspective
  • The learner will be able to explain specific effects of stress on performance and health based on a ‎‎scientifically validated stress model.‎
  • The leaner will be able to assess proven training results of stress management programs on ‎performance ‎and health.‎

TARGET AUDIENCE: Biofeedback and Applied Psychophysiology for the enhancement of performance ‎and health in life.‎

DIVERSITY CONSIDERATIONS: Stress is a universal aspect of life. The presentation therefore is designed ‎for providers and consumers of ‎stress management services.‎

 

 

‎4:30pm – 5:30pm    60-MINUTE BREAKOUT SESSIONS - SYMPOSIA

 

BOS12: What’s All the Noise About? Aperiodic Noise in the Brain and Its Colors of Pink, White and ‎Brown

Presented By: ‎

  • Tiff Thompson, PhD, R.EEG.T., BCN, QEEG-D, MFT

SESSION SYNOPSIS: This talk covers the fundamentals between signal (i.e. EEG rhythms and patterns) ‎and aperiodic noise in ‎the brain and the latest findings of aperiodicity, as well as its clinical application. ‎In the infancy and ‎childhood of life, there are rapid changes in the complexity and diversity of neurons ‎and neuronal ‎connections. At the same time there is lessening aperiodic activity and increasing ‎oscillatory frequencies ‎and signals occurring throughout the span of childhood, while overall ‎amplitude decreases. By seniority, ‎the signal to noise ratio is relatively flattened (i.e. periodic noise ‎increases), reflecting in lessened ‎neuroplasticity, resiliency, and malleability to change. ‎Until recently, aperiodic noise was thought to be “filler,” against which the signal was superimposed; ‎‎analogous to a blank canvas and colorful paint. New research is finding that there is information in the ‎‎noise, which likely hold undiscovered secrets to the inner working of the brain. Turns out, this 1/f ‎pattern ‎crops up frequently in many aspects of nature and phenomena like the stock market; some ‎believe it ‎represents a yet unknown law of nature.  This talk looks at the analysis of aperiodic noise, as ‎well as the ‎application of white noise, brown noise, and pink noise in neuromodulation. ‎

  • Hot Topics
  • Advanced
  • ‎37% Clinical/67% Research‎

LEARNING OBJECTIVES: ‎

  • Participants will be able to define pink noise from brown noise and white noise.‎
  • Participants will summarize an enhanced understanding of the principle of aperiodic noise in modern ‎‎neurology
  • Participants will be able to apply pink, white and brown noise in their clinical settings with an ‎enhanced ‎understanding of their respective utilities

TARGET AUDIENCE: Any and all interested in neuroanalysis (beginners to advanced)‎

DIVERSITY CONSIDERATIONS: The neurological phenomena covered in this talk are universal to all of ‎humanity.‎


BOS13: What Our QEEG May be Missing in Children’s Brains: Ethical Considerations for Practice

Presented By: ‎

  • Ronald J. Swatzyna, PhD, LCSW
  • Robert P. Turner, MD, MSCR, BCN, QEEG-D

SESSION SYNOPSIS: Children and adolescents are very difficult to treat, both with medication and ‎therapies including neurofeedback. Efforts to treat based solely on the presenting symptoms too often ‎fail. There may be neurological abnormalities that the quantitative electroencephalogram (qEEG) is ‎unable to discern. During this of rapid brain growth, as puberty approaches and hormonal surges ‎occur, we see a variety of ever-changing symptoms. Stimulants that address challenges with focus, ‎attention, and hyperactivity are prescribed first. Antidepressants are prescribed to treat anxiety. With ‎the onset of puberty, behavioral issues are commonly treated with antipsychotics. All stimulants, ‎antidepressants, and antipsychotics lower seizure threshold and increase the likelihood of brain ‎instability. At least a third of children and adolescents who have had a negative response to past ‎medication trials have isolated epileptiform discharges (IEDs). In a recent study of 772 children and ‎adolescents without epilepsy, we identified 286 (37%) to have IEDs. In the last decade, multiple studies ‎have found a high prevalence of IEDs across multiple diagnoses. As neurofeedback clinicians, we often ‎see children on multiple medications and, if they have IEDs, we are trying to counter factors that the ‎medication is making worse. QEEG brain mapping fails to identify IEDs for two reasons. First, the qEEG ‎artifacting process removes or averages out IEDs. Second, only a board certified ‎electroencephalographer has the training to detect subtle abnormalities.  Without this interpretation, ‎protocols to address the IEDs cannot be made from just the qEEG data alone as they will remain ‎unidentified. Psychiatrists need to be made aware of IEDs. Having a report from an MD who is a board ‎certified electroencephalographer goes a long way to a working relationship with treating psychiatrists.‎

  • Hot Topics
  • Intermediate
  • ‎50% Clinical/50% Research‎

LEARNING OBJECTIVES: ‎

  • What brain abnormalities can be made worse by commonly prescribed medications for children
  • What is a very common EEG abnormality in children and adolescents.‎
  • Why it is important to have the EEG read by an MD board certified in electroencephalography
  • Why it is ethically important for clinicians not to comment on what abnormalities they see in the EEG

TARGET AUDIENCE: This presentation is targeted for all of those who treat children and adolescents ‎even if they do not do qEEGs or neurofeedback.‎

DIVERSITY CONSIDERATIONS: EEG and qEEG data are blind to culture, race, or religious bias. This ‎demographics information is not collected.‎


ORAL04: Oral Presentations Session 4: Neurofeedback Focus

The following 30-minute abstract presentations will be featured: 1. Differentiating ‎Neurofeedback Paradigms: The Time has Come 2. Taking Neurofeedback Research to the Next Level: ‎Lessons from Literature and Research
 

Differentiating Neurofeedback Paradigms: The Time has Come

Presented By: ‎

  • Judy Carlson, EdD., MSN, APRN, BCN

SESSION SYNOPSIS: The time has come to differentiate the differing paradigms of Neurofeedback ‎‎(NFB). We now have paradigms of NFB that are vastly different in approach, protocols, and ‎mechanism of action.  Although, it is clear that all paradigms have degrees of efficacy, receiving one ‎type of NFB intervention is not the same as having another and the distinction is important to clarify to ‎neurofeedback community and the public at large.   Confusion abounds when articles are published ‎without the specificity of the paradigm indicated in the title nor is the reader clear of the mechanism of ‎action of the specific type of NFB used. Those that receive NFB usually do not know the paradigm, ‎name, or type of NFB received.  There is a general perspective that all neurofeedback is the exactly the ‎same.  However, NFB has grown from the alpha-theta and early Sensory-motor rhythm paradigms to ‎the focus on comprehensive assessments and treatment of dysrhythmic patterns of brain-waves and ‎blood oxygen levels.   Now with the newest paradigm, a break away from a operant conditioning ‎model, Infra-Low frequency (ILF) NFB is more of a endogenous neuromodulation model.  Described in ‎this presentation will be different paradigms assessment techniques, focus for improvement, training ‎model, mechanism of action, therapists role, the trainee's role and the self regulation process.‎

  • Hot Topics
  • Intermediate
  • ‎100% Clinical‎

LEARNING OBJECTIVES: ‎

  • differentiate 5 different paradigms of neurofeedback
  • summarize the mechanisms of the predominant neurofeedback paradigms
  • recognize the therapists and trainees role in the differing neurofeedback models

TARGET AUDIENCE: Biofeedback therapists, theorists, and scientists and those interested integrative ‎health modlaities.‎

DIVERSITY CONSIDERATIONS: Will be addressing the differing neurofeedback models and a new ‎cutting edge model that may change the neurofeedback operant conditioning culture and approach to ‎care.‎


Taking Neurofeedback Research to the Next Level: Lessons from Literature and Research

Presented By: ‎

  • Caitlin Tyrrell, PhD

SESSION SYNOPSIS: Neurofeedback using electroencephalography (EEG NF), and in particular infra-low ‎neurofeedback (IFL NFB), has generally demonstrated favorable outcomes, including reduction of ‎significant clinical symptoms. ILF NFB is hypothesized to increase regulatory functioning by providing ‎feedback to the brain on its present functionality that allows for self-correction through a process of ‎‎“endogenous neuromodulation” (Othmer, Othmer, Kaiser, & Putman, 2013). ILF NFB helps return the ‎brain to a baseline regulatory state of functioning that is thought to strengthen brain connectivity, ‎increase efficiency at the cellular level, and enhance functionality in the nervous system as a whole, ‎similar to the benefits of mindfulness and meditation. Given the recent development of ILF NFB, data ‎have been published from clinical settings, but at present no data from large controlled trials exist to ‎support efficacy of this treatment modality. Research available on EEG NFB more broadly presents ‎intriguing data on efficacy of the intervention, and at the same time has been met with challenges that ‎make it difficult to generalize findings and lead to critiques of comments on efficacy. Some of the key ‎concerns that have been raised include: adequacy of control conditions in being able to isolate the ‎effectiveness of EEG NFB above and beyond that of a placebo effect; difficulty with double-blind ‎research designs, given the nature of the intervention; small numbers of participants and ‎heterogeneity in research design impacting statistical significance and meaningful meta-analyses;  and ‎lack of clinical diagnostic outcomes or common measure of treatment efficacy reports. The present ‎discussion will endeavor to highlight critiques of the field and offer possible solutions for the ‎consideration of future research in this area, drawing from review of EEG NFB literature as well as the ‎challenges faced by clinical researchers conducting an ongoing randomized control trial of clinical ‎efficacy of ILF NFB among veterans.‎

  • Hot Topics
  • Intermediate
  • ‎100% Research‎

LEARNING OBJECTIVES: ‎

  • Discuss the challenges and successes in neurofeedback research;‎
  • Describe the placebo effect and the impact it can have on clinical and research data;‎
  • Apply principles from clinical trials in other diverse areas to neurofeedback research design.‎

TARGET AUDIENCE: Researchers in the area of EEG neurofeedback or anyone interested in research on ‎EEG neurofeedback

DIVERSITY CONSIDERATIONS: My proposal will address threats to internal and external validity of ‎neurofeedback research, which directly relates to translation of the data on neurofeedback efficacy to ‎clinical application with diverse clientele.‎

 

6:00pm - 7:15pm   

KEY02: Distinguished Scientist Lecture: The Integration of Lifestyle Change, Self-Care, and Professional ‎Treatment Interventions for Chronic Conditions: The Pathways Model                                                                                                                                                                

Presented by: Donald Moss, PhD, BCB, BCN, BCB-HRV


SESSION SYNOPSIS: The major challenge for human health in the 21st century is chronic diseases and ‎chronic conditions. This is a global problem, burdening health care systems and economies worldwide. ‎Factors contributing to the increase in chronic illness worldwide are aging populations, rapid ‎urbanization, and the globalization of unhealthy lifestyles.‎ Palliative medicine provides both medical and behavioral interventions offering relief from pain and ‎suffering caused by chronic conditions that are not amenable to cure. Lifestyle medicine emphasizes ‎reversing negative lifestyle elements that cause or exacerbate illness and introducing positive lifestyle ‎elements that enhance wellness.‎
The Pathways Model, developed by McGrady and Moss (2013, 2018), integrates features of both ‎palliative and lifestyle medicine.  The Pathways Model provides a step-wise framework for combining ‎patient-directed lifestyle change and self-care, skills acquisition, and the use of community resources, ‎with professionally administered treatment, to reduce suffering, manage illness, and optimize ‎mindbodyspirit wellness. The presenter will close with case narratives to illustrate the Pathways Model ‎and show the clinical benefit of coordinating lifestyle change and regular use of self-care strategies ‎with professional treatment interventions, for chronic medical illness and chronic mental health ‎disorders.‎

Donald Moss, PhD, BCB, is Dean, College of Integrative Medicine and Health ‎Sciences, at Saybrook University, Oakland, CA. There he has built training ‎programs in biofeedback, clinical hypnosis, integrative mental health, wellness ‎coaching, and integrative/functional nutrition. Dr. Moss is currently President of ‎the Society for Clinical and Experimental Hypnosis. He is also the ethics chair and ‎international certification chair for the Biofeedback Certification International ‎Alliance. He has served as president of Division 30 (hypnosis) of the American ‎Psychological Association, and president of the Association for Applied ‎Psychophysiology and Biofeedback (AAPB). He is also a member of the ‎International, Interdisciplinary, and Interreligious Research Group on ‎‎'Consciousness Studies,' at the Pontifical Academy, "Athenaeum Regina ‎Apostolorum," Rome, Italy. He has a book to be released in July 2018 with co-‎author Angele McGrady on Integrative Pathways: Navigating Chronic Illness with ‎a Mind-Body-Spirit Approach (Springer). He also has a book in preparation with ‎co-editor Inna Khazan on Mindfulness, Compassion, and Biofeedback Practice ‎‎(AAPB) and a book in preparation with co-editor Fredric Shaffer on Physiological ‎Recording Technology and Applications in Biofeedback and Neurofeedback ‎‎(AAPB). Moss is co-editor of Foundations of Heart Rate Variability Biofeedback ‎‎(AAPB, 2016), co-author of Pathways to Illness, Pathways to Health (Springer, ‎‎2013), and chief editor of Handbook of Mind-Body Medicine for Primary Care ‎‎(Sage, 2003) and Humanistic and Transpersonal Psychology (Greenwood, 1998).‎

  • Clinical Interventions and Optimal Performance
  • Intermediate
  • ‎70% Clinical/30% Research‎

LEARNING OBJECTIVES: ‎

  • Summarize global increase and global burden of chronic diseases and chronic conditions.‎
  • Recognize the role of aging, unhealthy lifestyle changes, and urbanization in the increasing the ‎incidence of chronic illness and chronic conditions.‎
  • Apply the Pathways Model to develop comprehensive patient-directed treatment plans, integrating ‎lifestyle change, the acquisition of skills, with biofeedback and other professional interventions.‎
  • Enhance the involvement of patients in active participation in their own healthcare and health ‎maintenance.‎

TARGET AUDIENCE: This address will be useful for practitioners in biofeedback, neurofeedback, and ‎lifestyle medicine, with guidance for the integrative care for medical and mental health disorders.‎

DIVERSITY CONSIDERATIONS: This invited address will include discussions of the need to adapt ‎treatment for diverse populations and the importance of cultural competence for effective treatment.‎

 

7:15 pm - 10:30 pm‎
President/Poster Reception and Synergy Lab Documentary Screen

REGISTER NOW

Wednesday, March 23, 2022‎

Thursday, March 24, 2022‎

Friday, March 25, 2022‎

Friday March 25, 2022 CONTINUED

Saturday, March 26, 2022‎

Saturday, March 26, 2022 CONTINUED

Follow AAPBiofeedback on Twitter
Follow 121999491198448 on Facebook
image widget